Literature DB >> 3484765

Expression of idiotype on the surface of human B cells producing anti-DNA antibody.

E Tamate, T Sasaki, T Muryoi, O Takai, K Otani, K Tada, K Yoshinaga.   

Abstract

We analyzed the idiotype (Id) expression on the surface of human anti-DNA antibody-producing cells. Murine monoclonal anti-Id antibodies with a specificity for determinants associated with the antigen-binding sites of human monoclonal anti-DNA autoantibodies were prepared. One anti-Id antibody reacted only with surface Id on anti-ssDNA-producing cells, but not with those on anti-dsDNA-producing B cell clones. Another anti-Id antibody did bind the surface Id on anti-dsDNA clones, but not those on anti-ssDNA clones. The interaction between anti-Id and surface Id was inhibited by pretreatment of the clones with DNA or appropriate polynucleotide antigens, or by preabsorption of anti-Id antibodies with free anti-DNA antibodies. Surface IgM and IgD expressed the same Id as the antibody secreted from the clones. The treatment of Id-positive clones by anti-Id antibody induced the redistribution of surface Id on the cells, indicating that these cells serve as targets for the regulatory action of anti-Id antibody.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484765

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Variable regions of a human anti-DNA antibody O-81 possessing lupus nephritis-associated idiotype.

Authors:  Y Hirabayashi; Y Munakata; T Sasaki; H Sano
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

2.  Epstein-Barr virus-transformed B cells bearing idiotypes of anti-DNA autoantibodies.

Authors:  O Takai; T Sasaki; T Muryoi; E Tamate; K Yoshinaga; H Sano
Journal:  J Clin Immunol       Date:  1988-05       Impact factor: 8.317

3.  Incidence of anti-DNA idiotype-positive cells in human peripheral blood.

Authors:  O Takai; T Sasaki; T Muryoi; N Harata; H Hashimoto; K Yoshinaga
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

4.  Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.

Authors:  N Harata; T Sasaki; H Osaki; T Saito; S Shibata; T Muryoi; O Takai; K Yoshinaga
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Binding specificity of antiidiotypic autoantibodies to anti-DNA antibodies in humans.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; H Saito; K Yoshinaga
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans.

Authors:  T Muryoi; T Sasaki; N Harata; O Takai; E Tamate; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.